Viewing Study NCT05027204


Ignite Creation Date: 2025-12-24 @ 9:09 PM
Ignite Modification Date: 2026-01-24 @ 5:42 PM
Study NCT ID: NCT05027204
Status: UNKNOWN
Last Update Posted: 2022-10-13
First Post: 2021-08-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Docetaxel for Injection (Albumin-bound) in Combination With Nivolumab in Patients With Head and Neck (SCCHN)
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Squamous Cell Carcinoma of Head and Neck View
Keywords: